A biotechnology company focused on developing cancer therapies.
AI-generated insights about Tango Therapeutics from various financial sources
A major 10% owner sold $5.11 million worth of stock. Historically, the stock has fallen an average of 42% in the three months following this specific owner's sales, creating a very strong warning signal.
A 10% owner made an unscheduled sale, and this insider's previous sales have been followed by an average stock decline of over 40% within three months, a very strong bearish signal.
A major 10% owner sold $5.11 million worth of stock. Historically, the stock has fallen an average of 42% in the three months following this specific owner's sales, creating a very strong warning signal.
A 10% owner made an unscheduled sale, and this insider's previous sales have been followed by an average stock decline of over 40% within three months, a very strong bearish signal.